Prof. Dr. Ingmar Glauche

2026

• Therapeutic Drug Monitoring of Imatinib in Paediatric Chronic Myeloid Leukaemia: Towards Practical Implementation and Interpretation of Measured Plasma ConcentrationsLensker, P., Gottschalk, A., Zerjatke, T., Roeder, I., Fromm, M. F., Dörje, F., Suttorp, M. & 3 others, Jul 2026, In: Clinical pharmacokinetics. 65, 7, p. 1013–1026, 14 p.Electronic (full-text) versionResearch output: Contribution to journal > Research article
• [¹⁸F]Fluorodeoxyglucose-PET/MRI-based response assessment following BCMA-directed CAR-T-cell therapy with ciltacabtagene autoleucel in relapsed/refractory multiple myelomaTeipel, R., Trautmann-Grill, K., Kleditsch, L., Epp, K., Böttcher, S., Röllig, C., Weidner, H. & 9 others, 21 May 2026, In: HaematologicaElectronic (full-text) versionResearch output: Contribution to journal > Letter
• Scientific education in German medical schools: nationwide cross-sectional study reveals student needs and gapsVogt, M., Geissler, M. E., Gerdes, S., Bereuter, J., Schuchardt, N., Geissler, R. B., Glauche, I. & 3 others, 2 May 2026, In: BMC medical education. 26, 1, 729Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Long-term clonal analysis using stochastic models reveals heterogeneity and quiescence of hematopoietic stem cellsVilela, Y. G., Thielecke, L., Fassoni, A. C. & Glauche, I., 31 Mar 2026, In: Computers in biology and medicine. 208, 10 p., 111650Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Dynamics of BCR::ABL1 transcript levels and clinical outcomes after switch to second-line therapy in pediatric chronic myeloid leukemiaSembill, S., Zerjatke, T., Winterstein, M., Ghete, T., Schirmer, E., Wotschofsky, Z., Suttorp, M. & 4 others, Mar 2026, In: HemaSphere. 10, 3, 6 p., e70347Electronic (full-text) versionResearch output: Contribution to journal > Letter
• Sequential BCR::ABL1 evaluation during dose de-escalation in peripheral blood is more predictive of TFR success than single assessment at dose de-escalation in either peripheral blood or bone marrowPatterson, S. D., Gottschalk, A., Hayden, C., Young, R., Hair, A., Jørgensen, H. G., Wheadon, H. W. & 5 others, Feb 2026, In: Leukemia. 40, 2, p. 459–463, 5 p.Electronic (full-text) versionResearch output: Contribution to journal > Letter

2025

• Prognostic Value of Multicolor-Flow Cytometric Measurable Residual Disease Detection in Acute Myeloid Leukemia Prior to Allogeneic Hematopoietic Cell Transplantation: Potential Role of HLA-DRRöhnert, M. A., Löffler, C., Kramer, M., Röllig, C., Schetelig, J., Stölzel, F., Kunadt, D. & 9 others, Dec 2025, In: Clinical Lymphoma, Myeloma and Leukemia. 25, 12, p. e1108-e1119.e2Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Tumor-Tissue Boundaries as Instructive Interfaces in Breast Cancer Cell InvasionClemens, C., Zerjatke, T., Frank, A., Trampert, H., Kotsiuba, N., Glauche, I. & Pompe, T., Nov 2025, In: Advanced Science. 12, 44, e09249Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Predicting treatment-free remission in chronic myeloid leukemia patients using an integrated model of tumor-immune dynamicsFassoni, A. C., Yong, A. S. M., Clark, R. E., Roeder, I. & Glauche, I., 16 Oct 2025, In: npj systems biology and applications. 11, 1, 115Electronic (full-text) versionResearch output: Contribution to journal > Research article
• Impact of exposure frequency on disease burden of the common cold - A mathematical modeling perspectiveGerdes, S., Rank, M., Glauche, I. & Roeder, I., Oct 2025, In: PloS one. 20, 10, e0334527Electronic (full-text) versionResearch output: Contribution to journal > Research article